Yang Molin, Luo Hanshen, Yi Xin, Wei Xiang, Jiang Ding-Sheng
Division of Cardiothoracic and Vascular Surgery Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China.
Department of Cardiology Renmin Hospital of Wuhan University Wuhan Hubei China.
MedComm (2020). 2023 May 22;4(3):e267. doi: 10.1002/mco2.267. eCollection 2023 Jun.
Ferroptosis is a form of regulated cell death triggered by the iron-dependent peroxidation of phospholipids. Interactions of iron and lipid metabolism factors jointly promote ferroptosis. Ferroptosis has been demonstrated to be involved in the development of various diseases, such as tumors and degenerative diseases (e.g., aortic dissection), and targeting ferroptosis is expected to be an effective strategy for the treatment of these diseases. Recent studies have shown that the regulation of ferroptosis is affected by multiple mechanisms, including genetics, epigenetics, posttranscriptional modifications, and protein posttranslational modifications. Epigenetic changes have garnered considerable attention due to their importance in regulating biological processes and potential druggability. There have been many studies on the epigenetic regulation of ferroptosis, including histone modifications (e.g., histone acetylation and methylation), DNA methylation, and noncoding RNAs (e.g., miRNAs, circRNAs, and lncRNAs). In this review, we summarize recent advances in research on the epigenetic mechanisms involved in ferroptosis, with a description of RNA N-methyladenosine (mA) methylation included, and the importance of epigenetic regulation in biological processes and ferroptosis-related diseases, which provides reference for the clinical application of epigenetic regulators in the treatment of related diseases by targeting ferroptosis.
铁死亡是一种由磷脂的铁依赖性过氧化作用引发的程序性细胞死亡形式。铁与脂质代谢因子的相互作用共同促进铁死亡。铁死亡已被证明参与多种疾病的发生发展,如肿瘤和退行性疾病(如主动脉夹层),靶向铁死亡有望成为治疗这些疾病的有效策略。最近的研究表明,铁死亡的调控受多种机制影响,包括遗传学、表观遗传学、转录后修饰和蛋白质翻译后修饰。表观遗传变化因其在调节生物过程中的重要性和潜在的可药物靶向性而备受关注。关于铁死亡的表观遗传调控已有许多研究,包括组蛋白修饰(如组蛋白乙酰化和甲基化)、DNA甲基化和非编码RNA(如miRNA、circRNA和lncRNA)。在本综述中,我们总结了铁死亡相关表观遗传机制的最新研究进展,包括RNA N-甲基腺苷(m⁶A)甲基化,并阐述了表观遗传调控在生物过程和铁死亡相关疾病中的重要性,这为通过靶向铁死亡将表观遗传调节剂应用于相关疾病的临床治疗提供参考。